00460 SIHUAN PHARM
Trading Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.73X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 16.4% | Net Margin | N/A |
| Total Debt/Equity | 19.8% | Return on Equity | N/A |
| Price/Book | 2.68X | Return on Assets | N/A |
| (HKD 1.340) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | -230.42 | -59.54 | -2,147.01 | 509.43 | 561.81 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -287.0 | +97.2 | -521.5 | -9.3 | +118.3 |
| Earnings Per Share (HKD) | -0.025 | -0.006 | -0.23 | 0.054 | 0.059 |
| Earnings Per Share Growth (%) | -289.1 | +97.2 | -526.1 | -9.1 | +118.3 |
| Dividend Per Share (HKD) | 0.021 | No dividend | 0.073 | 0.133 | 0.167 |
| P/E* (X) | N/A | N/A | N/A | 24.81 | 22.56 |
| Yield (%) | 1.57 | N/A | 5.44 | 9.93 | 12.44 |
| Dividend Share (%) | N/A | N/A | N/A | 246.30 | 280.64 |
| Book NAV (HKD) | 0.500 | 0.524 | 0.569 | 1.086 | 1.152 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 1,901 | 1,861 | +2.1 | 2,381 |
| Operating Result | -473.858 | -136.963 | +246.0 | -2,047 |
| Associates | -15.226 | -53.621 | -71.6 | -80.875 |
| Profit Before Taxation | -428.288 | -161.26 | +165.6 | -2,086 |
| Taxation | 43.261 | 96.427 | -55.1 | 196.935 |
| Profit /( Loss) After Taxation | -471.549 | -257.687 | +83.0 | -2,283 |
| Minority Interests | -254.887 | -203.67 | +25.1 | -368.358 |
| Net Profit | -216.662 | -54.017 | +301.1 | -1,915 |
| Earnings Per Share () | -0.0249 | -0.0064 | +289.1 | -0.2301 |
| Dividend Per Share () | 0.0210 | 0.0000 | N/A | 0.0729 |
| Announcement Date | 2025-03-28 | 2024-03-28 | NA | 2023-03-24 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
